{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:48:23Z","timestamp":1790470103264,"version":"4.1.0"},"reference-count":53,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>In primary aldosteronism (PA), aldosterone secretion is relatively independent of the renin\u2013angiotensin system, but can be regulated by several other stimuli.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To evaluate aldosterone response to several stimuli in a series of patients with PA secondary either to bilateral adrenal hyperplasia (BAH) or unilateral aldosterone-producing adenoma (APA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design and setting<\/jats:title>\n                  <jats:p>Prospective cohort study conducted in a university teaching hospital research center.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients<\/jats:title>\n                  <jats:p>Forty-three patients with confirmed PA and subtyped by adrenal vein sampling (n = 39) were studied, including 11 with BAH, 28 with APA, and 4 with undefined etiology. We also studied 4 other patients with aldosterone and cortisol cosecretion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Interventions<\/jats:title>\n                  <jats:p>We systematically explored aberrant regulation of aldosterone using an in vivo protocol that included the following stimulation tests performed over 3 days under dexamethasone suppression: upright posture, mixed meal, adrenocorticotropin (ACTH) 1-24, gonadotropin-releasing hormone (GnRH), vasopressin, and serotonin R4 agonist.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measures<\/jats:title>\n                  <jats:p>Positive response was defined as &amp;gt;50% renin or ACTH-independent increase in plasma aldosterone\/cortisol concentration following the various stimulation tests.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Renin-independent aldosterone secretion increased in response to several aberrant stimuli (upright posture, GnRH) in up to 83% of patients with APA or BAH in whom ACTH 1-24 and HT4R agonists also produced aldosterone oversecretion in all patients. The mean significant aberrant responses per patient was similar in BAH (4.6) and in APA (4.0).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Aldosterone secretion in PA is relatively autonomous from the renin\u2013angiotensin system, but is highly regulated by several other stimuli, which contributes to the large variability of aldosterone levels in PA patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa703","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T20:31:41Z","timestamp":1601584301000},"page":"e45-e60","source":"Crossref","is-referenced-by-count":52,"title":["Aldosterone is Aberrantly Regulated by Various Stimuli in a High Proportion of Patients with Primary Aldosteronism"],"prefix":"10.1210","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9791-2118","authenticated-orcid":false,"given":"Matthieu","family":"St-Jean","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Medicine and Research Center, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bourdeau","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine and Research Center, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of biochemistry, Clinical Department of Laboratory Medecine, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0225-2749","authenticated-orcid":false,"given":"Andr\u00e9","family":"Lacroix","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine and Research Center, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"issue":"6","key":"2021122204032329400_CIT0001","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev."},{"issue":"6018","key":"2021122204032329400_CIT0002","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science."},{"issue":"9","key":"2021122204032329400_CIT0003","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nat Genet."},{"issue":"9","key":"2021122204032329400_CIT0004","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat Genet."},{"issue":"4","key":"2021122204032329400_CIT0005","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat Genet."},{"issue":"10","key":"2021122204032329400_CIT0006","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2018-01004","article-title":"Targeted molecular characterization of aldosterone-producing adenomas in White Americans","volume":"103","author":"Nanba","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021122204032329400_CIT0007","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","article-title":"Cellular and genetic causes of idiopathic hyperaldosteronism","volume":"72","author":"Omata","year":"2018","journal-title":"Hypertension."},{"issue":"2","key":"2021122204032329400_CIT0008","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.beem.2018.01.003","article-title":"Aberrant G-protein coupled hormone receptor in adrenal diseases","volume":"32","author":"St-Jean","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"1","key":"2021122204032329400_CIT0009","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1677\/JOE-07-0037","article-title":"G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism","volume":"195","author":"Ye","year":"2007","journal-title":"J Endocrinol."},{"issue":"3","key":"2021122204032329400_CIT0010","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1210\/jc.2005-1298","article-title":"Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas","volume":"91","author":"Saner-Amigh","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122204032329400_CIT0011","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1210\/jc.2008-1340","article-title":"Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma","volume":"94","author":"Lampron","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122204032329400_CIT0012","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/EJE-08-0711","article-title":"Screening for membrane hormone receptor expression in primary aldosteronism","volume":"160","author":"Zwermann","year":"2009","journal-title":"Eur J Endocrinol."},{"key":"2021122204032329400_CIT0013","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fendo.2016.00072","article-title":"Role of ACTH and other hormones in the regulation of aldosterone production in primary aldosteronism","volume":"7","author":"El Ghorayeb","year":"2016","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"6","key":"2021122204032329400_CIT0014","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1530\/eje.1.02051","article-title":"Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas","volume":"153","author":"Cartier","year":"2005","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"2021122204032329400_CIT0015","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1210\/jc.2014-3551","article-title":"Diagnostic value of ACTH stimulation test in determining the subtypes of primary aldosteronism","volume":"100","author":"Jiang","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2021122204032329400_CIT0016","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1210\/jc.2011-0573","article-title":"Significance of adrenocorticotropin stimulation test in the diagnosis of an aldosterone-producing adenoma","volume":"96","author":"Sonoyama","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122204032329400_CIT0017","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/EJE-10-0879","article-title":"A case of primary aldosteronism in pregnancy: do LH and GNRH receptors have a potential role in regulating aldosterone secretion?","volume":"164","author":"Albiger","year":"2011","journal-title":"Eur J Endocrinol."},{"issue":"8","key":"2021122204032329400_CIT0018","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1210\/jc.2018-00087","article-title":"Genetic characterization of GnRH\/LH-responsive primary aldosteronism","volume":"103","author":"Gagnon","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122204032329400_CIT0019","first-page":"318","article-title":"LH, progesterone, and TSH can stimulate aldosterone in vitro: a study on normal adrenal cortex and aldosterone producing adenoma","volume":"46","author":"Nicolini","year":"2014","journal-title":"Horm Metab Res."},{"issue":"9","key":"2021122204032329400_CIT0020","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"April","key":"2021122204032329400_CIT0021","first-page":"1826","article-title":"Basal and post-ACTH aldosterone and its ratios are useful during adrenal vein sampling in primary aldosteronism","volume":"101","author":"Nada El","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2021122204032329400_CIT0022","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"2021122204032329400_CIT0023","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1210\/jc.2009-2010","article-title":"Adrenocortical zonation in humans under normal and pathological conditions","volume":"95","author":"Nishimoto","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122204032329400_CIT0024","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.110.158543","article-title":"Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism","volume":"56","author":"Boulkroun","year":"2010","journal-title":"Hypertension."},{"issue":"11","key":"2021122204032329400_CIT0025","first-page":"3570","article-title":"Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism","volume":"82","author":"Litchfield","year":"1997","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122204032329400_CIT0026","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1365-2265.2001.01253.x","article-title":"Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms","volume":"54","author":"Schubert","year":"2001","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3-4","key":"2021122204032329400_CIT0027","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3109\/07435809809032695","article-title":"ACTH receptor mRNA in human adrenocortical tumors: overexpression in aldosteronomas","volume":"24","author":"Arnaldi","year":"1998","journal-title":"Endocr Res."},{"issue":"12","key":"2021122204032329400_CIT0028","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1210\/jc.2019-01182","article-title":"Three discrete patterns of primary aldosteronism lateralization in response to cosyntropin during adrenal vein sampling","volume":"104","author":"Wannachalee","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122204032329400_CIT0029","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/jhh.2013.116","article-title":"A marked proportional rise in IVC aldosterone following cosyntropin administration during AVS is a signal to the presence of adrenal hyperplasia in primary aldosteronism","volume":"28","author":"Kline","year":"2014","journal-title":"J Hum Hypertens."},{"key":"2021122204032329400_CIT0030","doi-asserted-by":"crossref","DOI":"10.1210\/js.2019-SAT-063","article-title":"SAT-063 peripheral aldosterone values during simultaneous bilateral adrenal veins sampling","volume":"3","author":"St-Jean","year":"2019","journal-title":"J Endocr Soc."},{"issue":"3","key":"2021122204032329400_CIT0031","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1210\/jcem.87.3.8327","article-title":"Characterization of serotonin(4) receptors in adrenocortical aldosterone-producing adenomas: in vivo and in vitro studies","volume":"87","author":"Lefebvre","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021122204032329400_CIT0032","doi-asserted-by":"crossref","first-page":"E550","DOI":"10.1210\/jc.2014-3660","article-title":"Mast cell hyperplasia is associated with aldosterone hypersecretion in a subset of aldosterone-producing adenomas","volume":"100","author":"Duparc","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122204032329400_CIT0033","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.mce.2014.11.013","article-title":"Paracrine control of steroidogenesis by serotonin in adrenocortical neoplasms","volume":"408","author":"Lefebvre","year":"2015","journal-title":"Mol Cell Endocrinol."},{"issue":"1-2","key":"2021122204032329400_CIT0034","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2008.10.036","article-title":"G protein-coupled receptor expression in the adult and fetal adrenal glands","volume":"300","author":"Xing","year":"2009","journal-title":"Mol Cell Endocrinol."},{"issue":"15","key":"2021122204032329400_CIT0035","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1504869","article-title":"Pregnancy, primary aldosteronism, and adrenal CTNNB1 mutations","volume":"373","author":"Teo","year":"2015","journal-title":"N Engl J Med."},{"issue":"20","key":"2021122204032329400_CIT0036","doi-asserted-by":"crossref","first-page":"e3659","DOI":"10.1097\/MD.0000000000003659","article-title":"Gonadotropin-releasing hormone stimulate aldosterone production in a subset of aldosterone-producing adenoma","volume":"95","author":"Kishimoto","year":"2016","journal-title":"Medicine (Baltimore)."},{"issue":"7","key":"2021122204032329400_CIT0037","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tem.2008.06.003","article-title":"Is the adrenal cortex a target for gonadotropins?","volume":"19","author":"Bernichtein","year":"2008","journal-title":"Trends Endocrinol Metab."},{"issue":"April","key":"2021122204032329400_CIT0038","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1210\/jc.2007-2055","article-title":"Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes","volume":"93","author":"Mulatero","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2021122204032329400_CIT0039","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1210\/jc.2018-01394","article-title":"Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism","volume":"103","author":"Stowasser","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021122204032329400_CIT0040","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0735-1097(83)80333-7","article-title":"Impaired response of plasma vasopressin to orthostatic stress in patients with congestive heart failure","volume":"2","author":"Goldsmith","year":"1983","journal-title":"J Am Coll Cardiol."},{"issue":"3","key":"2021122204032329400_CIT0041","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1210\/endo.136.3.7867583","article-title":"Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin-II effect","volume":"136","author":"Guillon","year":"1995","journal-title":"Endocrinology."},{"issue":"12","key":"2021122204032329400_CIT0042","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1210\/jc.2002-020067","article-title":"Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia","volume":"87","author":"Mune","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122204032329400_CIT0043","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/cphy.c140065","article-title":"Hypothalamic-pituitary-adrenal axis\u2014feedback control","volume":"5","author":"Keller-Wood","year":"2015","journal-title":"Compr. Physiol."},{"issue":"11","key":"2021122204032329400_CIT0044","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0006-2952(97)00070-1","article-title":"1-desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor","volume":"53","author":"Saito","year":"1997","journal-title":"Biochem Pharmacol."},{"issue":"4","key":"2021122204032329400_CIT0045","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1210\/jc.2005-1453","article-title":"Evidence for a role of vasopressin in the control of aldosterone secretion in primary aldosteronism: in vitro and in vivo studies","volume":"91","author":"Perraudin","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"18","key":"2021122204032329400_CIT0046","doi-asserted-by":"crossref","first-page":"e92184","DOI":"10.1172\/jci.insight.92184","article-title":"Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing\u2019s syndrome","volume":"2","author":"Lecoq","year":"2017","journal-title":"JCI Insight."},{"issue":"8","key":"2021122204032329400_CIT0047","first-page":"3103","article-title":"Functional aspects of the effect of prolactin (PRL) on adrenal steroidogenesis and distribution of the PRL receptor in the human adrenal gland","volume":"81","author":"Glasow","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021122204032329400_CIT0048","first-page":"2029","article-title":"Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors","volume":"83","author":"Arnaldi","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122204032329400_CIT0049","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/hr.2010.18","article-title":"Sporadic solitary aldosterone- and cortisol-co-secreting adenomas: endocrine, histological and genetic findings in a subtype of primary aldosteronism","volume":"33","author":"Maser-Gluth","year":"2010","journal-title":"Hypertens Res."},{"issue":"12","key":"2021122204032329400_CIT0050","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1139\/y00-098","article-title":"Role of 5-HT in the regulation of the brain-pituitary-adrenal axis: effects of 5-HT on adrenocortical cells","volume":"78","author":"Contesse","year":"2000","journal-title":"Can J Physiol Pharmacol."},{"issue":"6","key":"2021122204032329400_CIT0051","first-page":"1029","article-title":"The biology of normal zona glomerulosa and aldosterone-producing adenoma: pathological implications","volume":"39","author":"Seccia","year":"2018","journal-title":"Endocr Rev."},{"key":"2021122204032329400_CIT0052","first-page":"57","article-title":"Functional implications of LH\/hCG receptors in pregnancy-induced Cushing syndrome","volume":"1","author":"Plockinger, Ursula","year":"2017","journal-title":"J Endocr Soc."},{"issue":"22","key":"2021122204032329400_CIT0053","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1056\/NEJMoa1215245","article-title":"Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia","volume":"369","author":"Louiset","year":"2013","journal-title":"N Engl J Med."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa703\/33822362\/dgaa703.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/1\/e45\/41847349\/dgaa703.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/1\/e45\/41847349\/dgaa703.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T04:09:59Z","timestamp":1640146199000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/1\/e45\/5916449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,9,30]]},"published-print":{"date-parts":[[2021,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa703","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,1]]},"published":{"date-parts":[[2020,9,30]]}}}